DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

Biogen Idec (NASDAQ: BIIB)

389.16 35.91 (10.17%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BIIB $389.16 10.17%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $372.75
Previous Close $353.25
Daily Range $372.75 - $397.00
52-Week Range $272.02 - $397.00
Market Cap $91.9B
P/E Ratio 33.45
Dividend (Yield) $0.00 (0.0%)
Volume 4,032,242
Average Daily Volume 1,831,213
Current FY EPS $13.47

Sector

Healthcare

Industry

Drugs

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/

News & Commentary

Why Biogen Idec's Shares Skyrocketed Higher

Biogen Idec reported impressive earnings results that sent shares up more than 10%.

Biogen Tops Q4 Earnings, Provides Strong Outlook for 2015 - Analyst Blog

Biogen Tops Q4 Earnings, Provides Strong Outlook for 2015 - Analyst Blog

Is the 'January Effect' Signaling a Down Year for the Stock Market?

Regeneron Shows Biotech Investors Have Left Their Wildcatting Days

IUSG, VZ, BIIB, HON: ETF Outflow Alert

Biogen, Intercept post double-digit gains

A Time To Cheer Or A Time To Cry

Biogen Idec (BIIB) Earnings Report: Q4 2014 Conference Call Transcript

Nasdaq 100 Movers: PCAR, AMZN

Did Biogen Run Too Much After Earnings?

See More BIIB News...

BIIB's Top Competitors

BIIB $389.16 (10.17%)
Current stock: BIIB
AMGN $152.26 (-2.63%)
Current stock: AMGN
GILD $104.83 (0.62%)
Current stock: GILD
$0.00 (0.00%)
Current stock: